Skip to main content

Johnson & Johnson (JNJ-N) Quote - Press Releases

Unchecking box will stop auto data updates
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

More stories below advertisement

Latest Press Releases

Thinking about trading options or stock in Walt Disney Co, Johnson & Johnson, Netflix, Target, or Walmart?
- PR Newswire - 1 hour ago
PR Newswire - CMTX
1 hour ago
InvestorsObserver issues critical PriceWatch Alerts for DIS, JNJ, NFLX, TGT, and WMT.
Thinking about trading options or stock in Walt Disney Co, Johnson & Johnson, Netflix, Target, or Walmart?
- PR Newswire - 1 hour ago
PR Newswire - PRNW
1 hour ago
NEW YORK , Aug. 21, 2019 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DIS, JNJ, NFLX, TGT, and WMT.
Cardinal Health, Inc. Investor Alert: Class Action Lawsuit Filed Against CAH
- PR Newswire - Tue Aug 20, 3:05PM CDT
PR Newswire - CMTX
Tue Aug 20, 3:05PM CDT
Thornton Law Firm LLP announces that a lawsuit has been filed on behalf of shareholders of Cardinal Health, Inc. (NYSE ticker: CAH). Investors who purchased CAH securities between March 2, 2015 and May 2, 2018, and are interested in learning about the case or serving as a lead plaintiff, are encouraged to visit www.tenlaw.com/cases/Cardinal to submit your information and learn more about the case. The lawsuit alleges that Cardinal Health violated the federal securities laws.
JOHNSON & JOHNSON INVESTIGATION UPDATE by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Johnson & Johnson - JNJ
- BusinessWire - Fri Aug 16, 9:50PM CDT
BusinessWire - CMTX
Fri Aug 16, 9:50PM CDT
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Johnson & Johnson ("J&J") (NYSE: JNJ).
Echosens Appoints Dominique Legros as Group CEO: Global Healthcare Business and Technology Expert Leads Company Growth in Chronic Liver Disease Assessment
- BusinessWire - Wed Aug 14, 9:03AM CDT
BusinessWire - CMTX
Wed Aug 14, 9:03AM CDT
Echosens, an innovative high-technology company offering the FibroScan family of products dedicated to assessment of chronic liver disease, announces the appointment of Dominique Legros as Group CEO, based at the corporate headquarters and offices in Paris, France. A senior-level business executive with diverse, international experience in both small companies and large global corporations, including Johnson & Johnson, Dentsply and Dentsply Sirona, Legros brings cultural sensitivity and significant expertise in successfully developing, transforming and leading enterprises worldwide, spanning France, Switzerland, Germany and the United States.
Global Breast Implants (Augmentation & Reconstruction) Markets, 2017-2018 & 2019-2023 with Profiles of Allergan,GC Aesthetics, Johnson & Johnson, Sientra
- PR Newswire - Wed Aug 14, 6:30AM CDT
PR Newswire - CMTX
Wed Aug 14, 6:30AM CDT
The "Global Breast Implants Market with Focus on Breast Augmentation & Breast Reconstruction: Size, Trends and Forecasts (2019-2023)" report has been added to ResearchAndMarkets.com's offering.
Legal Marijuana Market Likely to Emerge over a Period of 2019 - 2024 | Medicine Man, Canopy Growth, Aphria, Aurora Cannabis Inc., mCig Inc
- Reporthive Research - Wed Aug 14, 6:01AM CDT
Reporthive Research - CMTX
Wed Aug 14, 6:01AM CDT
Legal Marijuana Market Industry Global Market Research Report 2019 report also explains information about the market size, share, company growth, regional demands, trends, and technical analysis.
Global Monofocal IOLs Market 2019 Growth, Business Development, Competition Landscape and Emerging Trends with Focusing Key Players: Alcon, Novartis AG, Johnson & Johnson Vision Care, Carl Zeiss Meditec, HOYA Corporation
- Garth Media - Wed Aug 14, 4:47AM CDT
Garth Media - CMTX
Wed Aug 14, 4:47AM CDT
The global Monofocal IOLs market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
Watch for Johnson&Johnson to Potentially Pullback After Gaining 1.46% Yesterday
- Comtex SmarTrend(R) - Tue Aug 13, 11:51AM CDT
Comtex SmarTrend(R) - CMTX
Tue Aug 13, 11:51AM CDT
Johnson&Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $131.95 to a high of $133.94. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $132.76 on volume of 2.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Grenco Science and Vapium Announce Joint Venture to Introduce Accudose, a First-of-Its-Kind, Accurate Dosing Technology for Cannabis Consumption
- PR Newswire - Tue Aug 13, 9:07AM CDT
PR Newswire - CMTX
Tue Aug 13, 9:07AM CDT
Grenco Science, the leader in advanced technology cannabis vaporization, announces a joint venture with Vapium, the award-winning vaporization company and resident of Johnson & Johnson Innovation - JLABS (JLABS), and investee of Canopy Growth. The companies will work together to integrate ground-breaking technologies for the medical cannabis industry under the brand name Accudose. The first-of-its-kind cannabis consumption platform will fill a void in the market for an accurate, dosing protocol that will allow practitioners to prescribe cannabis as medicine, reframing cannabis consumption.

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).